Investegate |Galapagos NV Announcements | Galapagos NV: Gala

Investegate announcements from Galapagos NV, Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023

Related Keywords

United Kingdom , Mechelen , Region Flamande , Belgium , Japan , Canada , Northern Ireland , Craigavon , London , City Of , Japanese , Great Britain , Daniele Dambrosio , Ailsa Hart , Roberta Loveikyte , Kristina Harris , Pieter Jan Stiers , Katrien Van Beneden , Van Gijsel , Briang Feagan , Takayuki Matsumoto , Andreas Sturm , Christine Rudolph , Hannah Knight , Eva Santermans , Brian Feagan , Stefan Schreiber , Fatima Dawod , Tadakazu Hisamatsu , Karine Muller , Roger Rolph , Marieke Vermeersch , Edouard Louis , Sandra Cauwenberghs , Taku Kobayashi , Johan Burisch , Alessandra Oortwijn , Paul Van Hoek , Alessandro Armuzzi , Sarah Weatherby , Laurent Peyrin Biroulet , Corinne Jamoul , Katsuyoshi Matsuoka , Gerhard Rogler , Elisa Chenailler , Bart Eskens , Colitis Organization , Exchange Commission , Japanese Ministry Of Health , European Union , European Medicines Agency , Gilead Sciences Inc , European Crohn , Mayo Clinic Score , Danieled Ambrosio , Therapeutic Area Head , Inflammatory Bowel Disease , Western University , Ulcerative Colitis , Margaux Faes , Angela De Haas , Poster Exhibition , Meulen De Jong , Rachael Meadows , European Summary , Product Characteristics , Great Britain Summary , Northern Ireland Summary , Japanese Ministry , Gilead Sciences , Inflammatory Bowel Disease Questionnaire , Investegate Announcements , Investegate Company Announcements , Galapagos Nv , Lobenewswire , Lobenewswire And Globenewswire , Nw ,